Search of cellular protein(s) binding to the similar structure of HBV epsilon and HCV3'X

寻找与 HBV epsilon 和 HCV3X 相似结构结合的细胞蛋白

基本信息

  • 批准号:
    15590704
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

The genomic structures and replication mechanisms of hepatitis B virus (HBV) and hepatitis C virus (HCV) are different, but these two viruses share the biological characteristics; Both 1) take the form of RNA as the replicative intermediates, 2) are hepatotropic. 3) are not directly cytopathic but cause the persistent inflammation of the liver, predisposing occurrence of hepatocellular carcinoma (HCC). Epsilon structure of HBV RNA and 3'X structure of HCV RNA are indispensable for the replication or packaging of these viruses. We reported the similar secondary structures containing the identical 7 bases in both structures, and hypothesized that the biological similarity attributes to this structural similarity. As one of the steps to verify the hypothesis, we searched the cellular protein(s) recognizing this common structure. By SDS-southwestern method, 110 kDa, 35 kDa, and 15 kDa proteins were bound by the RNA or DNA oligomeres taking the form of this common structure. Of these 3 proteins, that of 35 kDa showed the strongest binding signal. To identify these protein(s), we examined the binding activity of 600 thousand clones of lambda gt11 expression libraries constructed from HepG2 cDNA by southwestern method. We isolated 4 independent clones. One of them was ribosomal binding protein L5 which was 34 kDa and compatible to the expected size. We are also analyzing other 3 clones. Our future task is to study the effect of these proteins on the replication of HBV or HCV.
乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)的基因组结构和复制机制不同,但这两种病毒具有共同的生物学特性;两者都以RNA的形式作为复制媒介,2)都是嗜肝的。3)不是直接的细胞病变,但引起肝脏持续炎症,易发生肝细胞癌(HCC)。HBV RNA的Epsilon结构和HCV RNA的3'X结构对于这些病毒的复制或包装是必不可少的。我们报道了相似的二级结构,在两个结构中含有相同的7个碱基,并假设生物相似性归因于这种结构相似性。作为验证这一假设的步骤之一,我们搜索了识别这种共同结构的细胞蛋白。通过sds -southwest方法,110 kDa、35 kDa和15 kDa蛋白被这种共同结构形式的RNA或DNA寡聚物结合。其中35kda蛋白的结合信号最强。为了鉴定这些蛋白,我们用西南法检测了由HepG2 cDNA构建的60万个lambda gt11表达文库的结合活性。我们分离了4个独立克隆。其中一个是核糖体结合蛋白L5,其大小为34 kDa,与预期大小相符。我们也在分析另外3个克隆体。我们未来的任务是研究这些蛋白对HBV或HCV复制的影响。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Similarity of the secondary structure with identical seven bases in the pregenomic / genomic regions required for the replication of hepatitis B virus and hepatitis C virus.
乙型肝炎病毒和丙型肝炎病毒复制所需的前基因组/基因组区域中具有相同七个碱基的二级结构的相似性。
  • DOI:
  • 发表时间:
    2002
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kajino K;Hino O.
  • 通讯作者:
    Hino O.
Similarity of the secondary structure with identical seven bases in the pregenomic/genomic regions required for the replication of hepatitis B virus and hepatitis C virus
乙型肝炎病毒和丙型肝炎病毒复制所需的前基因组/基因组区域具有相同七个碱基的二级结构的相似性
Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAJINO Kazunori其他文献

KAJINO Kazunori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAJINO Kazunori', 18)}}的其他基金

Role of dbpA in hepatocarcinogenesis
dbpA 在肝癌发生中的作用
  • 批准号:
    18590748
  • 财政年份:
    2006
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Hepatocarcinogesis and Genomic Instability: Functional Analysis of Y-box binding protein.
肝癌和基因组不稳定性:Y-box 结合蛋白的功能分析。
  • 批准号:
    12670537
  • 财政年份:
    2000
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

The 13th Canadian Symposium on Hepatitis C Virus (CSHCV)
第13届加拿大丙型肝炎病毒研讨会(CSHCV)
  • 批准号:
    487828
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Miscellaneous Programs
Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒 (HCV) 感染受控人类感染模型 (CHIM) 关键方面的表征
  • 批准号:
    478700
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
治愈之后:衡量直接作用抗病毒药物对加拿大艾滋病毒/丙型肝炎病毒合并感染者的全面影响
  • 批准号:
    469805
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
  • 批准号:
    10449670
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
A Simple at-home test for rapid and accurate screening for Hepatitis C Virus (HCV) exposure
简单的家庭测试,可快速、准确地筛查丙型肝炎病毒 (HCV) 暴露
  • 批准号:
    10709130
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
Workshop for the development of a Controlled Human Infection Model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒(HCV)感染的受控人类感染模型(CHIM)开发研讨会
  • 批准号:
    460792
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Miscellaneous Programs
Rapid, Point-of-Care Diagnostics for Hepatitis C Virus
丙型肝炎病毒的快速护理点诊断
  • 批准号:
    10683045
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
  • 批准号:
    10620846
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)
直接作用抗病毒药物预防丙型肝炎病毒感染供者肾移植至未感染受者的随机对照试验 (PREVENT-HCV)
  • 批准号:
    10597168
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
The effect of opioids, stimulants, and the simultaneous use of both on the hepatitis C virus (HCV) cascade of care in rural communities in the United States
阿片类药物、兴奋剂以及同时使用两者对美国农村社区丙型肝炎病毒 (HCV) 级联护理的影响
  • 批准号:
    10459753
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了